N-(4-Chlorophenyl)-1,3,5-triazine-2,4-diamine

CAS: 500-42-5

Ref. 3D-FC125742

Produktinformation

• Name: N-(4-Chlorophenyl)-1,3,5-triazine-2,4-diamine
• Synonyme: 1,3,5-triazine-2,4-diamine, N-(4-chlorophenyl)-, 1,3,5-Triazine-2,4-diamine, N-(4-chlorophenyl)-, 1,3,5-Triazine-2,4-diamine, N²-(4-chlorophenyl)-, 2-(p-Chloroanilino)-4-amino-s-triazine, 2-Amino-4-(p-chloroanilino)-1,3,5-triazine, 2-Amino-4-p-chloroanilino-s-triazine, 2-N-(4-Chlorophenyl)-1,3,5-triazine-2,4-diamine, Asa 226, Chlorazinil, Chloroazinal, Diurazine, Diurazyna, L-Mimosine (leucenol), N-(4-chlorophenyl)-1,3,5-triazine-2,4-diamine, N-(p-Chlorophenyl)-2,4-diamino-s-triazine, N²-(4-Chlorophenyl)-1,3,5-triazine-2,4-diamine, Neo-Urofort, Neurofort, Orpizin, Riker 545, Skf 3195, Triazurol, s-Triazine, 2-amino-4-(p-chloroanilino)-, N2-(4-Chlorophenyl)-1,3,5-triazine-2,4-diamine, 1,3,5-Triazine-2,4-diamine, N2-(4-chlorophenyl)-

Beschreibung

N-(4-Chlorophenyl)-1,3,5-triazine-2,4-diamine is a chemical compound that has been shown to be effective in treating primary pulmonary hypertension. It also has antibacterial efficacy against gram-positive bacteria and an alkanoic acid with antihypertensive activity. The compound is used as a specific treatment for muscle diseases and heart tissue. This drug inhibits the production of pyrazinoic acid from the metabolism of N-(4-chlorophenyl)-1,3,5-triazine-2,4-diamine by blocking the enzyme pyrazinoyl transferase. It has been found to inhibit the synthesis of mRNA by binding to the 5'-hydroxyl group of guanosine residues in RNA molecules.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 221.65 g/mol
• Formel: C₉H₈ClN₅
• Reinheit: Min. 95%
• InChl: InChI=1S/C9H8ClN5/c10-6-1-3-7(4-2-6)14-9-13-5-12-8(11)15-9/h1-5H,(H3,11,12,13,14,15)
• InChI Key: InChIKey=YRZQHIVOIFJEEE-UHFFFAOYSA-N
• SMILES: Nc1ncnc(Nc2ccc(Cl)cc2)n1